Immuno-Biological Laboratories Co., Ltd.

¥915.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4570Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 1.19%
Div yield 0.82%
ROE 21.32%
Biotechnology
Beta (5Y) (0.10)
PE TTM 23.09
TSR TTM 97.62%
Mkt cap ¥8.522B
ROIC 11.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥999
9.22%
(2.68%)
Hold 8|4|7|5|5
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
14.99
16.37
16.41
16.99
17.96%
25.68%
15.23%
24.58%
Revenue¥M
760.9
768.7
779.9
808.5
5.58%
0.73%
4.98%
4.07%
Peers (US$54.11M)
Cap (US$)
PE
64.32M
—
Capital
TTM
5Y
10Y
Leveragex
1.487
0.156
0.147
EBIT/Intx
1.414
0.264
0.265
Own earn%
41.49
46.64
38.91
Sh yield%
24.95
12.31
12.16
Owners
Insiders/Inst%
3.10
61.95
Short interest%
5.02
SBC / revenue%
0.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
20–29
$1 testx
—
Incr. ROIC%
10